Watch Ticker

NewAmsterdam Pharma Company N.V. Ordinary Shares

Go to NewAmsterdam Pharma Company N.V. Ordinary Shares Website

$21.70

0.04 (0.21%)

Live

Previous Close

$21.66

Day Range

$21.62 - $22.39

Previous Day Range

$21.24 - $21.84

Market Cap

$2.4 billion USD

Day Vol.

359638

Previous Day Vol.

422526

Currency

USD

Primary Exchange

Nasdaq

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial

NewAmsterdam Pharma announced positive results from a pre-specified Alzheimer's disease biomarker analysis in its Phase 3 BROADWAY trial, showing statistically significant reductions in key biomarkers in both the full study population and in ApoE4 carriers. The findings support the potential of obicetrapib, a CETP inhibitor, to prevent Alzheimer's disease progression.

Related tickers: NAMS, NAMSW.

Read Full Article

N/A - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma, a late-stage biopharmaceutical company, announced the grant of inducement share options and restricted stock units to new hires, including the new Chief People Officer. The grants are aimed at incentivizing and retaining key personnel.

Related tickers: NAMS, NAMSW.

Read Full Article

Trending Tickers

Please sign in to view